| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 01/30/2003 | US20030022935 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical agents |
| 01/30/2003 | CA2454059A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 01/30/2003 | CA2453633A1 Aryl substituted thiazolidinones and the use thereof |
| 01/30/2003 | CA2453294A1 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 01/29/2003 | EP1279729A1 Factors participating in degranulation of mast cells, dnas encoding the same, method of screening inhibitors of these factors and the inhibitors |
| 01/29/2003 | EP1278754A1 Cephalosporin intermediates |
| 01/29/2003 | EP1278723A2 P-(sulfonyl)-aryl and -heteroaryl amines |
| 01/29/2003 | EP1278722A1 Aryl and heteroaryl sulfonates |
| 01/28/2003 | WO2002010155A1 Substituted aryl ketones and their use as herbicides |
| 01/28/2003 | US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/28/2003 | US6511988 Prevention binding of transcription factor tozinc finger binding compounds |
| 01/28/2003 | US6511941 Synergistic mixture |
| 01/28/2003 | CA2417385A1 Substituted aryl ketones and their use as herbicides |
| 01/28/2003 | CA2254905C Tricyclic functional dyes for contrast enhancement in optical imaging |
| 01/23/2003 | WO2003006453A1 Aminediols for the treatment of alzheimer's disease |
| 01/23/2003 | WO2003006447A2 Interaction inhibitors of tcf-4 with beta-catenin |
| 01/23/2003 | WO2003006443A2 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003006021A1 Alpha-hydroxyamide statine derivatives for the treatment of alzh eimer's disease |
| 01/23/2003 | WO2003006015A1 Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands |
| 01/23/2003 | WO2003006013A1 Diaminediols for the treatment of alzheimer's disease |
| 01/23/2003 | WO2002098367A3 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity |
| 01/23/2003 | WO2002055491A3 1,2-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLORPROTEASES AND TNF-$g(a) |
| 01/23/2003 | US20030018070 Bisaryl compound and medicament for cancer treatment comprising the same |
| 01/23/2003 | US20030018059 Antiinflammatory agents; antihistamines; antiallergens |
| 01/23/2003 | US20030018057 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 01/23/2003 | US20030018034 Piperazine compounds and medicinal use thereof |
| 01/23/2003 | US20030018022 Antiinflammatory agents; antiallergens |
| 01/23/2003 | US20030018016 Cell adhesion inhibitors |
| 01/23/2003 | US20030017164 Dye-azide compounds for dual phototherapy |
| 01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | CA2453451A1 Aminediols for the treatment of alzheimer's disease |
| 01/23/2003 | CA2453447A1 Alpha-hydroxyamide statine derivatives for the treatment of alzheimer's disease |
| 01/23/2003 | CA2453444A1 Diaminediols for the treatment of alzheimer's disease |
| 01/23/2003 | CA2453175A1 Interaction inhibitors of tcf-4 with beta-catenin |
| 01/22/2003 | EP1277752A1 Process for producing optically active sulfoxide derivative |
| 01/22/2003 | EP1277745A1 Novel stable crystal of thiazolidinedione derivative and process for producing the same |
| 01/22/2003 | EP1277743A1 Oxa(thia)zolidine derivative and anti-inflammatory drug |
| 01/22/2003 | EP1277729A1 Ppar (gamma) modulators |
| 01/22/2003 | EP1276732A1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation" |
| 01/22/2003 | EP1276730A2 Thiazolidinedione analogues and their use for the treatment of diabetes |
| 01/22/2003 | EP1276726A2 Substituted phenyl farnesyltransferase inhibitors |
| 01/22/2003 | EP1276714A2 Cyclic carboxylic acids as integrin antagonists |
| 01/22/2003 | EP1071660B1 N-sulphonyl and n-sulphinyl phenylglycinamide |
| 01/22/2003 | CN1392144A 3-amino-2-mercapto phenyl formic acid erivative and its preparation |
| 01/22/2003 | CN1392137A New cyclic alpha-amino-gamma hydroxy amide compound, its preparing method and medicinal composition containing said compound |
| 01/22/2003 | CN1099284C Aryloxy propyl amine compound for treatment of incontinence of urine |
| 01/21/2003 | US6509474 Method of lithiating five membered heterocycles |
| 01/21/2003 | US6509363 P38 is a mitogen-activated protein kinase; pyrrole, oxazole, thiazole, and imidazole derivatives |
| 01/21/2003 | US6509354 3-arylphenyl sulfide derivative and insecticide and miticide |
| 01/21/2003 | CA2026690C Pleuromutilins |
| 01/17/2003 | WO2002006269A1 Cyclic amino acid derivatives |
| 01/17/2003 | CA2415964A1 Cyclic amino acid derivatives |
| 01/16/2003 | WO2003005025A1 Methods for identifying compounds modulating the activity of ppar-gamma |
| 01/16/2003 | WO2003004480A2 Substituted piperazine and diazepanes as histamine h3 receptor agonists |
| 01/16/2003 | WO2003004479A1 4-aryl quinols and analogs thereof as therapeutic agents |
| 01/16/2003 | WO2003004478A1 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea and its use in the treatment of conditions associated with glycogen-synthase kinase-3(gsk3) |
| 01/16/2003 | WO2003004467A2 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 01/16/2003 | WO2003004458A1 New compounds |
| 01/16/2003 | WO2003004020A1 Heteroaryl carboxylic acid amides, the production thereof and the use of the same as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 01/16/2003 | WO2003003806A2 Dye-azide compounds for dual phototherapy |
| 01/16/2003 | WO2002070467B1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 01/16/2003 | WO2002046129A3 Inhibitors of histone deacetylase |
| 01/16/2003 | US20030013892 Production of chirally pure alpha-amino acids and N-sulfonyl alpha-amino acids |
| 01/16/2003 | US20030013847 Pyruvate derivatives |
| 01/16/2003 | US20030013846 Cytoprotective agents |
| 01/16/2003 | US20030013751 Viricides; enzyme inhibitors |
| 01/16/2003 | US20030013749 Alkali metal salt of thiazolidine-2,4-dione derivative |
| 01/16/2003 | US20030013748 Anticancer agents |
| 01/16/2003 | US20030013747 Novel substituted 1-aryl-3-heteroaryl-thioureas and substituted 1-aryl-3-heteroaryl-isothioureas as antiatherosclerotic agents |
| 01/16/2003 | US20030013725 Amino acid derivatives |
| 01/16/2003 | US20030013715 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 01/16/2003 | US20030013657 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | US20030013656 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | US20030013041 Write-once optical data carrier |
| 01/16/2003 | CA2452609A1 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use |
| 01/16/2003 | CA2452592A1 4-aryl quinols and analogs thereof as therapeutic agents |
| 01/15/2003 | EP1275648A1 Epothilone minor constituents |
| 01/15/2003 | EP1274705A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders |
| 01/15/2003 | EP1274695A1 New thiazol compounds and their preparations |
| 01/15/2003 | EP0934938B1 Substituted benzoylaminothiazole derivatives and drugs containing the same |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391555A Benzamides and related inhibitors of factor Xa |
| 01/15/2003 | CN1391474A 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 01/15/2003 | CN1391473A VLA-4 inhibitor compounds |
| 01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
| 01/15/2003 | CN1098849C 噻唑衍生物 Thiazole derivatives |
| 01/15/2003 | CN1098841C Novel amide derivatives and medicinal compositions thereof |
| 01/15/2003 | CN1098838C Substituted N-(indole-2-carbonyl)-beta-alanimamides and derivatives as antidiabetic agents |
| 01/14/2003 | US6506903 By reacting 4-methylthiazole with N-halosuccinimide in solvent in presence of 2,2-azobisisobutyronitrile; halogenation, catalysis |
| 01/14/2003 | US6506902 Alkylation of a thiazole compound |
| 01/14/2003 | US6506876 LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use |
| 01/14/2003 | US6506787 Aids therapy |
| 01/14/2003 | US6506780 Benzophenones and sulfones as inhibitors of glycine uptake |
| 01/14/2003 | US6506757 Carboxylic acid derivatives and drugs containing the same as the active ingredient |
| 01/14/2003 | US6506755 Thiazolidinecarboxyl acids |
| 01/14/2003 | US6506751 Thiazolidinone compounds useful as chemokine inhibitors |
| 01/14/2003 | US6506517 Surface modified carbonaceous materials |
| 01/09/2003 | WO2003002596A2 Use of dipeptidyl peptidase iv inhibitors as therapeutics for neurological disorders |
| 01/09/2003 | WO2003002595A2 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents |